세계의 니티놀 기반 의료기기 시장 보고서(2025년)
Nitinol Based Medical Device Global Market Report 2025
상품코드 : 1760653
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 175 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,482,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,370,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,257,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

니티놀 기반 의료 기기 시장 규모는 향후 몇 년 동안 급속한 성장을 보일 것으로 예상됩니다. 예측 기간 동안의 예상 성장은 최소 침습 시술에 대한 수요 증가, 로봇 보조 수술에서 니티놀의 사용 증가, 환자별 맞춤형 임플란트에 대한 관심 증가, 신경혈관 및 구조적 심장 중재에 대한 응용 분야 확대, 혁신적인 기기에 대한 지원적인 규제 프레임워크 등 여러 요인에 의해 촉진될 것입니다. 예측 기간 동안의 주요 동향으로는 최소 침습 기기 설계의 혁신, 생체 적합성 코팅의 개선, 스마트 센서 기술과의 통합, 형상 기억 스텐트 및 임플란트의 개발, 로봇 보조 수술의 채택 등이 있습니다.

심혈관 질환(CVD)의 유병률이 증가함에 따라 니티놀 기반 의료 기기 시장은 앞으로 몇 년 동안 성장을 이어갈 것으로 예상됩니다. 심혈관 질환은 관상동맥 질환, 심근경색, 심부전, 부정맥, 뇌졸중 등 심장과 혈관 질환을 포괄합니다. 이러한 질환은 일반적으로 혈관의 협착 또는 폐쇄로 인해 심장과 다른 장기로의 혈류와 산소 공급이 제한됩니다. 심혈관 질환의 증가 추세는 특히 선진국에서 인구 고령화에 기인하며, 연령이 증가함에 따라 CVD 위험이 높아집니다. 니티놀 기반 의료 기기는 니티놀(니켈과 티타늄의 합금)의 독특한 특성으로 인해 심혈관 질환의 치료 및 관리에 매우 효과적임이 입증되었습니다. 예를 들어, 미국 심장 협회(American Heart Association)는 2024년 1월 심혈관 질환으로 인한 사망자 수가 93만 1,578명에 달하고, 2023년 92만 8,741명에서 증가했다고 보고했습니다. 정사망률은 약간 상승해, 10만명당 233.3명이 되어, 전년의 224.4명으로부터 4.0% 상승했습니다.그 결과, 심혈관 질환의 유병률 증가가 심혈관 카테터 시장을 견인하고 있습니다.

니티놀 기반 의료기기 시장 기업들은 수술 효율성을 향상시키고 환자 회복을 개선하기 위해 자급 확장형 니티놀 스텐트-전극과 같은 혁신적인 솔루션을 개발하는 데 집중하고 있습니다. 자급 확장형 니티놀 스텐트-전극은 체내에 삽입되면 미리 설정된 형태로 자동 확장되는 니티놀 스텐트로 제작된 하이브리드 장치입니다. 이 기기에는 신경, 혈관, 뇌 등 생물학적 조직으로부터 전기 자극이나 기록을 위해 설계된 내장형 전극이 포함되어 있습니다. 예를 들어, 2024년 9월 미국 기업 Synchron은 자체 확장형 니티놀 스텐트-전극 배열을 사용하는 Stentrode BCI 임플란트를 출시했습니다. 이 장치는 경정맥을 통해 운동 피질 근처의 상부 사지동맥으로 전달되며, 약 20분 내에 최소 침습적 삽입이 가능합니다. 얇은 디자인(1.3mm 전극)과 낮은 방사력으로 정맥 손상을 최소화하며, 플래티넘 전극은 운동 의도를 디지털 제어 위해 해독합니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 - 금리, 인플레이션, 지정학, 무역전쟁과 관세, 코로나 19 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별, 국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

HBR
영문 목차

영문목차

Nitinol-based medical devices are healthcare instruments made from a nickel-titanium alloy known for its shape memory and superelastic characteristics. These devices are designed to adapt to body movements or temperature changes, making them suitable for minimally invasive procedures. Common uses include orthopedic implants, surgical tools, and dental devices.

The main product categories in nitinol-based medical devices include stents, guidewires, retrieval devices, catheters, and others. Stents are small, tube-shaped implants that help keep narrowed or blocked blood vessels open. These devices are used in various medical fields such as cardiovascular care, urology, dentistry, and more. They are primarily employed in hospitals, ambulatory surgical centers, specialty clinics, and other healthcare settings.

The nitinol based medical device market research report is one of a series of new reports from The Business Research Company that provides nitinol based medical device market statistics, including the nitinol based medical device industry global market size, regional shares, competitors with the nitinol based medical device market share, detailed nitinol based medical device market segments, market trends, and opportunities, and any further data you may need to thrive in the nitinol based medical device industry. This nitinol based medical device market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The nitinol-based medical device market size has grown rapidly in recent years. It will grow from $18.99 billion in 2024 to $21.06 billion in 2025 at a compound annual growth rate (CAGR) of 10.9%. The growth during the historical period can be attributed to factors such as the rising demand for minimally invasive procedures, the increasing prevalence of cardiovascular and orthopedic conditions, the growing geriatric population, the enhanced biocompatibility and flexibility of Nitinol, the expansion of healthcare infrastructure, and favorable regulatory approvals for innovative devices.

The nitinol-based medical device market size is expected to see rapid growth in the next few years. It will grow to $31.6 billion in 2029 at a compound annual growth rate (CAGR) of 10.6%. The projected growth in the forecast period is driven by factors including the rising demand for minimally invasive procedures, the increasing use of Nitinol in robotic-assisted surgeries, a growing focus on patient-specific and customizable implants, expanding applications in neurovascular and structural heart interventions, and supportive regulatory frameworks for innovative devices. Key trends during the forecast period include innovations in minimally invasive device design, enhanced biocompatibility coatings, integration with smart sensor technologies, the development of shape-memory stents and implants, and the adoption of robotic-assisted surgeries.

The rising prevalence of cardiovascular diseases (CVD) is expected to drive the growth of the nitinol-based medical device market in the coming years. Cardiovascular diseases encompass a variety of heart and blood vessel disorders, such as coronary artery disease, heart attacks, heart failure, arrhythmias, and stroke. These conditions typically involve the narrowing or blockage of blood vessels, which limits blood flow and oxygen to the heart and other organs. The increase in cardiovascular diseases can be attributed to aging populations, especially in developed countries, where the risk of CVD increases with age. Nitinol-based medical devices have proven to be highly effective in treating and managing cardiovascular diseases due to the unique properties of nitinol, an alloy of nickel and titanium. For example, the American Heart Association, a U.S.-based nonprofit organization, reported in January 2024 that the number of deaths caused by cardiovascular diseases reached 931,578, up from 928,741 in 2023. Additionally, the age-adjusted death rate from CVD increased slightly, reaching 233.3 per 100,000, a 4.0% rise from the previous year's rate of 224.4 per 100,000. As a result, the growing prevalence of cardiovascular diseases is driving the market for cardiovascular catheters.

Companies in the nitinol-based medical device market are focusing on developing innovative solutions, such as self-expanding nitinol stent-electrodes, to enhance surgical efficiency and improve patient recovery. A self-expanding nitinol stent-electrode is a hybrid device made from a nitinol stent that automatically expands into a predetermined shape once deployed in the body. It also features embedded electrodes designed for electrical stimulation or recording from biological tissues such as nerves, blood vessels, or the brain. For example, in September 2024, U.S.-based company Synchron introduced its Stentrode BCI implant, which uses a self-expanding nitinol stent-electrode array. This device is delivered via the jugular vein to the superior sagittal sinus near the motor cortex, allowing minimally invasive placement in approximately 20 minutes. The thin design (1.3mm lead) with low radial force minimizes venous damage, while the platinum electrodes decode motor intent for digital control.

In November 2022, Sweden-based alloy company Alleima AB acquired Endosmart Gesellschaft fur Medizintechnik GmbH (Endosmart) for an undisclosed amount. This acquisition strengthens Alleima's position in the medical sector by enhancing its product portfolio, expanding its market presence, and creating operational synergies through shared resources and cross-selling opportunities. Endosmart, based in Germany, specializes in designing and manufacturing medical devices and components using nitinol, a shape-memory alloy.

Major players in the nitinol based medical device market are Medtronic plc, Zimmer Biomet Holdings, Ametek Inc., Arthrex, Teleflex Incorporated, Nordson Medical, Cook Medical, Cordis, Seisa Medical, Fort Wayne Metals, Confluent Medical Technologies, Norman Noble Inc., Endologix, Resonetics, GEE Nitinol, Balton, EndoSmart GmbH, Ingpuls Medical, Vascotube, and Metalwerks PMD.

North America was the largest region in the nitinol-based medical device market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in nitinol-based medical device report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the nitinol-based medical device market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The nitinol-based medical device market consists of sales of products including nitinol, orthopedic fixation devices, endoscopic components, surgical sutures, dental archwires, embolic protection devices, and spinal implants. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Nitinol Based Medical Device Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on nitinol based medical device market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for nitinol based medical device ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The nitinol based medical device market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Nitinol Based Medical Device Market Characteristics

3. Nitinol Based Medical Device Market Trends And Strategies

4. Nitinol Based Medical Device Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Nitinol Based Medical Device Growth Analysis And Strategic Analysis Framework

6. Nitinol Based Medical Device Market Segmentation

7. Nitinol Based Medical Device Market Regional And Country Analysis

8. Asia-Pacific Nitinol Based Medical Device Market

9. China Nitinol Based Medical Device Market

10. India Nitinol Based Medical Device Market

11. Japan Nitinol Based Medical Device Market

12. Australia Nitinol Based Medical Device Market

13. Indonesia Nitinol Based Medical Device Market

14. South Korea Nitinol Based Medical Device Market

15. Western Europe Nitinol Based Medical Device Market

16. UK Nitinol Based Medical Device Market

17. Germany Nitinol Based Medical Device Market

18. France Nitinol Based Medical Device Market

19. Italy Nitinol Based Medical Device Market

20. Spain Nitinol Based Medical Device Market

21. Eastern Europe Nitinol Based Medical Device Market

22. Russia Nitinol Based Medical Device Market

23. North America Nitinol Based Medical Device Market

24. USA Nitinol Based Medical Device Market

25. Canada Nitinol Based Medical Device Market

26. South America Nitinol Based Medical Device Market

27. Brazil Nitinol Based Medical Device Market

28. Middle East Nitinol Based Medical Device Market

29. Africa Nitinol Based Medical Device Market

30. Nitinol Based Medical Device Market Competitive Landscape And Company Profiles

31. Nitinol Based Medical Device Market Other Major And Innovative Companies

32. Global Nitinol Based Medical Device Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Nitinol Based Medical Device Market

34. Recent Developments In The Nitinol Based Medical Device Market

35. Nitinol Based Medical Device Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기